Google recently announced the launch of its new open-source model, TxGemma, designed to significantly improve the efficiency of therapeutic drug development. Developed by the Google DeepMind team, this model is a fine-tuned version of their advanced Gemma model family, incorporating powerful natural language understanding, scientific prediction, and multi-turn dialogue capabilities. TxGemma aims to revolutionize drug discovery. Its release is considered a significant advancement in the application of AI to biomedicine, promising to drastically shorten the time it takes for drugs to move from the lab to clinical trials, while also reducing costs.